3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Withdrawal of Dupilumab in Severe AsthmaHypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorderRecruitingPhase 42026-10-08NCT06818019
Ruxolitinib Treatment in Inclusion Body MyositisInclusion Body Myopathy, Sporadic, inclusion body myositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular diseaseRecruitingPhase 22026-05-29NCT06536166
Cohort IMEA 070 -Lenacapavir CompassionalBlood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted diseaseActive, not recruitingNot stated2024-10-26NCT06289361